Partial protection against Brucella infection in mice by immunization with nonpathogenic alphaproteobacteria.
Previous findings indicate that Brucella antigens and those from nonpathogenic alphaproteobacteria (NPAP) are cross-recognized by the immune system. We hypothesized that immunization with NPAP would protect mice from Brucella infection. Mice were immunized subcutaneously with heat-killed Ochrobactrum anthropi, Sinorhizobium meliloti, Mesorhizobium loti, Agrobacterium tumefaciens, or Brucella melitensis H38 (standard positive control) before intravenous challenge with Brucella abortus 2308. Cross-reacting serum antibodies against Brucella antigens were detected at the moment of challenge in all NPAP-immunized mice. Thirty days after B. abortus challenge, splenic CFU counts were significantly lower in mice immunized with O. anthropi, M. loti, and B. melitensis H38 than in the phosphate-buffered saline controls (protection levels were 0.80, 0.66, and 1.99 log units, respectively). In mice immunized intraperitoneally with cytosoluble extracts from NPAP or Brucella abortus, protection levels were 1.58 for the latter, 0.63 for O. anthropi, and 0.40 for M. loti. To test whether the use of live NPAP would increase protection further, mice were both immunized and challenged by the oral route. Immunization with NPAP induced a significant increase in serum immunoglobulin G (IgG), but not serum or fecal IgA, against Brucella antigens. After challenge, anti-Brucella IgA increased significantly in the sera and feces of mice orally immunized with O. anthropi. For all NPAP, protection levels were higher than those obtained with systemic immunizations but were lower than those obtained by oral immunization with heat-killed B. abortus. These results show that immunization with NPAP, especially O. anthropi, confers partial protection against Brucella challenge. However, such protection is lower than that conferred by immunization with whole Brucella or its cytosoluble fraction.
Delpino
M Victoria
MV
Instituto de Estudios de la Immunidad Humoral (IDEHU, CONICET-UBA), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, 1113 Buenos Aires, Argentina.
Estein
Silvia M
SM
Fossati
Carlos A
CA
Baldi
Pablo C
PC
D016960:Agrobacterium tumefaciens / Q000276:immunology*; D000818:Animals; D002004:Brucella Vaccine / Q000276:immunology*; D002003:Brucella abortus / Q000276:immunology*; D017347:Brucella melitensis / Q000276:immunology*; D002006:Brucellosis / Q000276:immunology* / Q000517:prevention & control*; D006358:Hot Temperature; D051379:Mice; D020621:Ochrobactrum anthropi / Q000276:immunology*; D016962:Sinorhizobium meliloti / Q000276:immunology*; D015164:Vaccines, Inactivated / Q000276:immunology
D002004:Brucella Vaccine; D015164:Vaccines, Inactivated
Plant Physiol. 2001 Dec;127(4):1484-92
11743092
Infect Immun. 2001 Aug;69(8):4816-22
11447155
Trends Cell Biol. 2002 Mar;12(3):121-9
11859024
Vaccine. 2002 Feb 22;20(11-12):1660-9
11858876
J Clin Microbiol. 2002 Apr;40(4):1475-80
11923376
Infect Immun. 2002 May;70(5):2535-43
11953393
Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):13148-53
12271122
Vet Microbiol. 2002 Dec 20;90(1-4):165-82
12414142
Vet Microbiol. 2002 Dec 20;90(1-4):209-27
12414145
Pediatr Infect Dis J. 2003 Feb;22(2):183-6
12586984
Microbes Infect. 2003 Feb;5(2):85-93
12650766
Infect Immun. 2003 Oct;71(10):5750-5
14500496
Vaccine. 2004 Sep 3;22(25-26):3435-9
15308369
Clin Diagn Lab Immunol. 2004 Sep;11(5):868-73
15358645
Can J Public Health. 1966 May;57(5):225-31
4956571
Infect Immun. 1978 May;20(2):347-51
669801
Prog Clin Biol Res. 1980;47:107-17
6163155
J Clin Invest. 1982 Apr;69(4):742-9
7042755
Ann Rech Vet. 1983;14(2):163-8
6614793
Infect Immun. 1987 Apr;55(4):899-908
3549565
Lancet. 1993 Sep 25;342(8874):805
8103891
Clin Infect Dis. 1994 Jun;18(6):914-20
8086552
FEMS Immunol Med Microbiol. 1995 Apr;11(2):81-6
7640675
Clin Diagn Lab Immunol. 1997 May;4(3):279-84
9144364
Vaccine. 1999 Jan 28;17(4):353-61
9987174
J Bacteriol. 2005 Apr;187(8):2715-26
15805518
Infect Immun. 2005 Oct;73(10):6537-46
16177328
Infect Immun. 2006 May;74(5):2734-41
16622210
J Infect. 2000 May;40(3):287-90
10908026
Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):443-8
11756688